Insurance Company Ends PrEP Coverage UPDATE: Company Reverses Decision reports:

Assurant Health, a national company specializing in health insurance coverage for individuals and small businesses, will no longer cover the med Truvada as pre-exposure prophylaxis (PrEP) to prevent contracting HIV. Several Assurant customers who had been taking Truvada (comprising the antiretrovirals tenofovir and emtricitabine) as PrEP were recently notified that the insurer would end coverage of the med in July. “Prophylactic treatment is not a covered benefit as listed in the Exclusion Section of your member contract,” read one customer’s notice (see below). “As a courtesy we will allow two additional months of prescription coverage for your Truvada prescription. This means you will continue to receive prescription drug card benefits for Truvada at CVSC Specialty Pharmacy until July 1, 2015.”

Truvada as a daily HIV preventive has been approved by the FDA and endorsed by the CDC. Last week the parent company of Assurant revealed that next year it will either sell or shut down the insurer because they can no longer refuse to cover high-risk patients due to the implementation of the Affordable Care Act.

UPDATE: This just in: “Hello, I wanted to provide the following updated information to you. Here is our statement. We are reversing our decision and will be reaching out to policyholders who received the letter. Thank you, Mary Hinderliter, Vice President, Assurant Health.”